Home Other Building Blocks Trans-styrylacetic acid

Trans-styrylacetic acid

CAS No.:
1914-58-5
Catalog Number:
AG002F7R
Molecular Formula:
C10H10O2
Molecular Weight:
162.1852
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$38
- +
5g
98%
In Stock USA
United States
$150
- +
25g
98%
In Stock USA
United States
$600
- +
Product Description
Catalog Number:
AG002F7R
Chemical Name:
Trans-styrylacetic acid
CAS Number:
1914-58-5
Molecular Formula:
C10H10O2
Molecular Weight:
162.1852
MDL Number:
MFCD00002783
IUPAC Name:
(E)-4-phenylbut-3-enoic acid
InChI:
InChI=1S/C10H10O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-7H,8H2,(H,11,12)/b7-4+
InChI Key:
PSCXFXNEYIHJST-QPJJXVBHSA-N
SMILES:
OC(=O)C/C=C/c1ccccc1
Properties
Complexity:
167  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
162.068g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
162.188g/mol
Monoisotopic Mass:
162.068g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
37.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Fragrance material review on 4-phenyl-3-buten-2-ol. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20120901
Synthesis and antimalarial and antituberculosis activities of a series of natural and unnatural 4-methoxy-6-styryl-pyran-2-ones, dihydro analogues and photo-dimers. Bioorganic & medicinal chemistry 20120215
p38 MAPK activation, JNK inhibition, neoplastic growth inhibition, and increased gap junction communication in human lung carcinoma and Ras-transformed cells by 4-phenyl-3-butenoic acid. Journal of cellular biochemistry 20120101
Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processing. Antioxidants & redox signaling 20110401
Probing the peptidylglycine alpha-hydroxylating monooxygenase active site with novel 4-phenyl-3-butenoic acid based inhibitors. ChemMedChem 20100903
Anti-inflammatory effects of 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester, potential inhibitors of neuropeptide bioactivation. The Journal of pharmacology and experimental therapeutics 20070301
Study of polarized IR spectra of the hydrogen bond system in crystals of styrylacetic acid. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20061001
Isolation and antifungal activity of 4-phenyl-3-butenoic acid from Streptomyces koyangensis strain VK-A60. Journal of agricultural and food chemistry 20051005
Streptomyces koyangensis sp. nov., a novel actinomycete that produces 4-phenyl-3-butenoic acid. International journal of systematic and evolutionary microbiology 20050101
Peptidyl-glycine alpha-amidating monooxygenase targeting and shaping of atrial secretory vesicles: inhibition by mutated N-terminal ProANP and PBA. Circulation research 20041210
Reversal of the transformed phenotype and inhibition of peptidylglycine alpha-monooxygenase in Ras-transformed cells by 4-phenyl-3-butenoic acid. Molecular carcinogenesis 20041201
Oleic acid derived metabolites in mouse neuroblastoma N18TG2 cells. Biochemistry 20041005
Glycine-extended adrenomedullin exerts vasodilator effect through amidation in the rat aorta. Regulatory peptides 20030515
Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells. Journal of molecular and cellular cardiology 20021101
The phenylacetyl-CoA catabolon: a complex catabolic unit with broad biotechnological applications. Molecular microbiology 20010301
Properties